Journal
MOLECULES
Volume 26, Issue 2, Pages -Publisher
MDPI
DOI: 10.3390/molecules26020384
Keywords
prostate cancer; bone metastasis; nanotechnology; nanomedicine
Funding
- MD Anderson Institutional Grant
Ask authors/readers for more resources
Nanotechnology is being used to enhance the diagnosis and treatment of prostate cancer bone metastases, as current interventions are only palliative and do not significantly improve survival times.
Patients with advanced prostate cancer can develop painful and debilitating bone metastases. Currently available interventions for prostate cancer bone metastases, including chemotherapy, bisphosphonates, and radiopharmaceuticals, are only palliative. They can relieve pain, reduce complications (e.g., bone fractures), and improve quality of life, but they do not significantly improve survival times. Therefore, additional strategies to enhance the diagnosis and treatment of prostate cancer bone metastases are needed. Nanotechnology is a versatile platform that has been used to increase the specificity and therapeutic efficacy of various treatments for prostate cancer bone metastases. In this review, we summarize preclinical research that utilizes nanotechnology to develop novel diagnostic imaging tools, translational models, and therapies to combat prostate cancer bone metastases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available